Related Experiment Video

Updated: Aug 8, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

An analysis of the catalytic cycle of HIV-1 reverse transcriptase: opportunities for chemotherapeutic intervention

P A Furman1, G R Painter, K S Anderson

  • 1Triangle Pharmaceuticals, 4 University Place, 4611 University Drive, Durham, NC 27707, USA.

Current Pharmaceutical Design
|May 2, 2000
PubMed

Insights

This review details the HIV-1 reverse transcriptase catalytic cycle, identifying key inhibition points for antiviral drug development. Understanding molecular forces aids in designing novel inhibitors to block viral replication.

Area of Science:

  • Biochemistry and Molecular Biology
  • Virology
  • Medicinal Chemistry

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) reverse transcriptase is a critical enzyme for viral replication.
  • Current antiretroviral therapies include nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs).
  • NRTIs act as chain terminators or directly inhibit the enzyme, while NNRTIs bind allosterically, reducing catalytic efficiency.

Purpose of the Study:

  • To comprehensively review the catalytic cycle of HIV-1 reverse transcriptase.
  • To evaluate each step of the catalytic cycle as a potential target for therapeutic inhibition.
  • To analyze the molecular forces governing natural substrate binding and specificity for rational drug design.

Main Methods:

  • Detailed description of the sequential steps in the HIV-1 reverse transcriptase catalytic cycle.
  • Evaluation of each catalytic step's potential as an inhibition target.
  • Analysis of molecular forces (e.g., binding affinities, specificity) of natural catalytic complex components.

Main Results:

  • Identification of specific enzymatic steps amenable to inhibition.
  • Characterization of the mechanisms of action for existing NRTI and NNRTI drug classes.
  • Elucidation of molecular interactions critical for enzyme function and substrate recognition.

Conclusions:

  • Each step in the HIV-1 reverse transcriptase catalytic cycle presents a viable target for antiviral intervention.
  • A detailed understanding of molecular forces can guide the development of more effective and specific inhibitors.
  • Further exploration of these inhibition points holds promise for advancing HIV-1 treatment strategies.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...